Prothena Corporation plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$1.16 | -$1.16 | -$1.16 |
| Q2 2024 | 4 | -$1.06 | -$1.06 | -$1.06 |
| Q3 2024 | 8 | -$1.27 | -$1.02 | -$1.15 |
| Q4 2024 | 4 | -$1.00 | -$1.00 | -$1.00 |
| Q1 2025 | 4 | -$1.42 | -$1.42 | -$1.42 |
| Q2 2025 | 5 | -$1.46 | -$1.46 | -$1.46 |
| Q3 2025 | 4 | -$1.53 | -$1.53 | -$1.53 |
| Q4 2025 | 5 | -$1.59 | -$1.59 | -$1.59 |
Prothena Corporation plc Earnings Date And Information
Prothena Corporation plc last posted its earnings results on Thursday, August 8th, 2024. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $-1.05 by $2.27. The company had revenue of 132.01 M for the quarter and had revenue of 91.37 M for the year. Prothena Corporation plc has generated $-3 earnings per share over the last year ($-2.76 diluted earnings per share) and currently has a price-to-earnings ratio of -23.11. Prothena Corporation plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Prothena Corporation plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$1.05 | $1.24 | 2.29 | $10.73 M | $132.01 M |
| 05/08/2024 | Q1 2024 | -$1.21 | -$1.34 | -0.13 | $50,000 | |
| 02/22/2024 | Q4 2023 | -$1.26 | $316,000 | |||
| 11/02/2023 | Q3 2023 | -$0.32 | $0.41 | 0.73 | $41.69 M | $84.87 M |
| 08/03/2023 | Q2 2023 | -$0.92 | -$1.03 | -0.11 | $5.09 M | $4.02 M |
| 05/04/2023 | Q1 2023 | -$0.83 | -$0.89 | -0.06 | $2.17 M | |
| 02/28/2023 | Q4 2022 | $0.13 | $49.92 M | |||
| 11/03/2022 | Q3 2022 | -$0.31 | -$0.97 | -0.66 | $25.22 M | $1.52 M |
| 08/08/2022 | Q2 2022 | -$0.51 | -$0.88 | -0.37 | $1.31 M | |
| 05/05/2022 | Q1 2022 | -$0.85 | -$0.78 | 0.07 | $1.15 M | |
| 02/25/2022 | Q4 2021 | -$0.71 | $7.12 M | $1.17 M | ||
| 11/04/2021 | Q3 2021 | $2.28 | $2.39 | 0.11 | $140.05 M | $139.17 M |
| 08/05/2021 | Q2 2021 | $1.00 | $0.62 | -0.38 | $70.20 M | $60.07 M |
| 05/11/2021 | Q1 2021 | -$0.80 | -$0.91 | -0.11 | $160,000 | |
| 02/26/2021 | Q4 2020 | -$0.77 | $182,762 | $360,000 | ||
| 11/04/2020 | Q3 2020 | -$0.68 | -$0.77 | -0.09 | $160,833 | $157,000 |
| 08/06/2020 | Q2 2020 | -$0.64 | -$0.66 | -0.02 | $150,000 | $195,000 |
| 05/06/2020 | Q1 2020 | -$0.60 | -$0.59 | 0.01 | $141,000 | |
| 03/03/2020 | Q4 2019 | -$0.54 | $175,000 | $256,000 | ||
| 11/05/2019 | Q3 2019 | -$0.54 | -$0.49 | 0.05 | $175,000 | $205,000 |
Prothena Corporation plc Earnings: Frequently Asked Questions
-
When is Prothena Corporation plc's earnings date?
Prothena Corporation plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
Did Prothena Corporation plc beat their earnings estimates last quarter?
In the previous quarter, Prothena Corporation plc (:PRTA) reported $1.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.05 by $2.27.
-
How can I listen to Prothena Corporation plc's earnings conference call?
The conference call for Prothena Corporation plc's latest earnings report can be listened to online.
-
How can I read Prothena Corporation plc's conference call transcript?
The conference call transcript for Prothena Corporation plc's latest earnings report can be read online.
-
How much revenue does Prothena Corporation plc generate each year?
Prothena Corporation plc (:PRTA) has a recorded annual revenue of $91.37 M.
-
How much profit does Prothena Corporation plc generate each year?
Prothena Corporation plc (:PRTA) has a recorded net income of $91.37 M. Prothena Corporation plc has generated $-2.76 earnings per share over the last four quarters.
-
What is Prothena Corporation plc's price-to-earnings ratio?
Prothena Corporation plc (:PRTA) has a price-to-earnings ratio of -23.11 and price/earnings-to-growth ratio is -0.91.
